Some users run goal-oriented cycles continuing until target weight loss, then cycling off
Long-acting agents like Exenatide (once weekly), Liraglutide, Dulaglutide, Semaglutide, and several others have been favored for use based on data from comparative trails
While regulatory bodies and pharmaceutical companies are discussing potential solutions to the drug shortages, societies such as the American Diabetes Association are providing guidelines to assist with alternative treatment options for patients with type 2 diabetes mellitus as well as guidelines to assist with dosage changes to be made while GLP-1 therapies are low in stock
Perkovic V, de Zeeuw D, Mahaffey KW, Fulcher G, Erondu N, Shaw W, et al
That disciplined approach outperforms guesswork and glossy advertising in the long run
Does Aetna cover Zepbound for prediabetes or metabolic syndrome